Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)-Reference-Cited by-同舟云学术

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2)

Published:2018-08 Issue:2 Volume:79 Page:302-314.e6
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Gottlieb Alice B.,Blauvelt Andrew,Thaçi Diamant,Leonardi Craig L.,Poulin Yves,Drew Janice,Peterson Luke,Arendt Catherine,Burge Daniel,Reich Kristian

Publisher

Elsevier BV

Subject

Dermatology

Reference26 articles.

1. The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis;Dowlatshahi;J Invest Dermatol,2014

2. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey;Krueger;Arch Dermatol,2001

3. Quality-of-life issues in psoriasis;Mukhtar;Dermatol Clin,2004

4. Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare Registry;Piaserico;J Am Acad Dermatol,2014

5. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011;Armstrong;JAMA Dermatol,2013

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment strategies for Spondyloarthritis: Implementation of precision medicine – Or “one size fits all” concept?;Autoimmunity Reviews;2024-09

2. Psoriasis as a systemic disease;Deutsches Ärzteblatt international;2024-07-12

3. Biologics for Psoriasis;Dermatologic Clinics;2024-07

4. Biologika als „game changer“;Deutsche Dermatologie;2024-07

5. Certolizumab Pegol for the Treatment of Plaque Psoriasis in Routine Clinical Practice: One-Year Results from the CIMREAL Study;Dermatology and Therapy;2024-06-27